Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2000
12/27/2000EP1062239A2 Ribonucleotide polypeptides containing metal
12/27/2000EP1062237A1 Ribonucleotide polypeptides containing metal
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1062226A1 High affinity nucleic acid ligands of complement system proteins
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1062201A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors
12/27/2000EP1061944A2 Therapeutic chemokine receptor antagonists
12/27/2000EP1061921A1 Vitronectin receptor antagonists
12/27/2000EP1061908A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP1061805A1 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2000EP1061803A1 Novel compositions of eprosartan
12/27/2000EP1061800A1 Compositions and methods for modulating vascularization
12/27/2000EP0891322B1 Dimethyl-substituted cyclohexane diene derivatives
12/27/2000CN1278269A Piperazine-cyclodextrin complexes
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278252A 4,5-diaryloxazole compounds
12/27/2000CN1278251A Novel carboxylic acid derivatives which carry amide side chains, prodn. of same, and use as endothelin receptor antagonists
12/27/2000CN1278250A Vitronectin receptor antagonists
12/27/2000CN1278246A Dofetilide polymorphs
12/27/2000CN1278244A Dipeptide nitriles
12/27/2000CN1278182A Citrus peel extract as inhibitor of acyl CoA-cholesterol-0-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall
12/27/2000CN1278180A Method for treating hypercholesterolemia by using unsubstituted polydiallylamine
12/27/2000CN1278178A Use of macrolies for treating cancer and macular degeneration
12/27/2000CN1278175A Compositions of lipid lowering agents
12/27/2000CN1278007A Human interleukin 2 derivatives and human heart sodium medium fusion gene, its protein products and use thereof
12/27/2000CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277961A Novel 2,3-methylene amino acid compound, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277867A Medicine for treating angitis, and its prodn. method
12/27/2000CN1277864A External application medicine for treating hypertension
12/27/2000CN1277855A Traditional Chinese medicine prepn. for warming heart and inducing arteries and veins contg. ginseng and monkshood
12/27/2000CN1277847A Isomaltooligose oral liquor for treating diabetes and hypertension, and method for preparing same
12/27/2000CN1277846A Pharmaceuticals for treating outer skin blood vessel diease in cold seasons
12/27/2000CN1059905C Rapamycin hydroxyesters, process for their preparation and pharmaceutical compositions containing them
12/27/2000CN1059902C Estrogen excitant/antagonist
12/27/2000CN1059829C Nourishing heart and rising heart rhythm drink and preparation method
12/27/2000CN1059828C Pear hypotensor capsules and preparation thereof
12/27/2000CN1059823C Medicinal liquor for body-building and treating rheumatism
12/27/2000CN1059820C Method for preparing angiocardiopathy medicine
12/27/2000CN1059813C Cardio- and cerebro-angiopathy curing drop pellet and its preparation method
12/27/2000CN1059805C Capsule for treating cerebral arteriosclerosis
12/26/2000US6166227 Preparation of (S)-2-amino-6, 6-dimethoxyhexanoic acid methyl ester via novel dioxolanes
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166090 Prevention atherosclerosis; administering transforming growth factor
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166060 Antihistamines; sleep disorders; central nervous system disorders
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6166040 Treating a disorder of the central nervous system
12/26/2000US6166035 1,4-dihydropyridine derivatives and their use in therapy
12/26/2000US6166034 Spiro piperidine derivatives as 5HT1D receptor antagonists
12/26/2000US6166030 An inhibitors of the neuronal isoform of nitric oxide synthase; treating hypoxia, stroke, ischaemia, neurodegenerative conditions, schizophrenia, pain, migraine
12/26/2000US6166027 Treatment of high blood pressure and cardiac insufficiency, angina pectoris, arrhythmias, thromboembolic diseases, ischaemias, myocardial infarction, cerebral stroke, restenoses, coronary angioplasties, arteriosclerosis
12/26/2000US6166025 A stable, aqueous drug formulation for treating migraine
12/26/2000US6166022 Treatment of platelet aggregation disorders and angina
12/26/2000US6166020 Aryl and heteroaryl alkoxynaphthalene derivatives
12/26/2000US6166017 Method of using ketoconazole and related substances in medicaments for treatment of type II diabetes and methods of treating same
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165732 Drug screening by using lipid bilayer that has potassium- or chloride-selective channel formed from polpeptide of bcl-2 family, contacting compound with bilayer, and determining ion-selectivity of channel; indicates agonist or antagonist
12/26/2000CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077246A2 A METHOD FOR IDENTIFYING A DRUG CANDIDATE HAVING AN INHIBITORY ACTION ON FVII-TF ACTIVITY, AND FVIIa/TF ACTIVITY INHIBITING COMPOUNDS
12/21/2000WO2000077237A1 49 human secreted proteins
12/21/2000WO2000077226A1 22025, a novel human cyclic nucleotide phosphodiesterase
12/21/2000WO2000077221A1 Hyaluronidase from the hirudinaria manillensis, isolation, purification and recombinant method of production
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077190A2 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000WO2000077184A1 Caspase-8 crystals, models and methods
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077173A1 42 human secreted proteins
12/21/2000WO2000077035A2 Novel potassium channels and genes encoding these potassium channels
12/21/2000WO2000077022A1 50 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000077000A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076999A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076998A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076997A1 New bispidine compounds useful in the treatment of cardiac arrhythmias
12/21/2000WO2000076980A1 Novel nitrogen-contaiing heterocyclic derivatives or salts thereof
12/21/2000WO2000076972A1 N-cyclopentyl modulators of chemokine receptor activity
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076953A1 Benzene derivatives, preparation method and pharmaceutical compositions containing same
12/21/2000WO2000076544A1 Aminotetralin derivative for the therapy of cardiovascular diseases
12/21/2000WO2000076536A1 Use of adenosine to minimize reperfusion injury
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076528A2 Pharmaceutical preparation containing proteins
12/21/2000WO2000076523A1 Methods for modulating fxr receptor activity
12/21/2000WO2000076517A1 Il-8 receptor antagonists
1 ... 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 ... 1595